-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
- Lyell Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 256M shares, a 1.99% increase year-over-year.
- Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 251M shares, a 1.58% increase from 2022.
- Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 247M shares, a 81.8% increase from 2021.
- Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 136M shares, a 925% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)